DIFLUNISAL
NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES · RHEUMATOID ARTHRITIS ·+3
TEVA USA
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
DIPYRIDAMOLE
ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW · THROMBOEMBOLISM DUE TO PROSTHETIC HEART VALVES
GSK Consumer Healthcare
EFFIENT (prasugrel HCl)
ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW · MYOCARDIAL REINFARCTION PREVENTION ·+1
Eli Lilly and Company
AGGRASTAT (tirofiban HCl monohydrate in 0.9 % sodium chloride)
GLYCOPROTEIN IIB/IIIA RECEPTOR INHIBITOR · NON Q-WAVE MYOCARDIAL INFARCTION ·+3
MEDICURE INTERN
BRILINTA (ticagrelor)
ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW · MYOCARDIAL REINFARCTION PREVENTION ·+4
AstraZeneca Pharmaceuticals
DIPYRIDAMOLE
ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW · THROMBOEMBOLISM DUE TO PROSTHETIC HEART VALVES
RISING PHARM
CILOSTAZOL
INTERMITTENT CLAUDICATION AGENTS · INTERMITTENT CLAUDICATION
TEVA USA
CILOSTAZOL
INTERMITTENT CLAUDICATION AGENTS · INTERMITTENT CLAUDICATION
APOTEX CORP
DIFLUNISAL
NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES · RHEUMATOID ARTHRITIS ·+3
RISING PHARM
WARFARIN SODIUM
ORAL ANTICOAGULANTS · MYOCARDIAL REINFARCTION PREVENTION ·+12
TARO PHARM USA
JANTOVEN (warfarin sodium)
ORAL ANTICOAGULANTS · MYOCARDIAL REINFARCTION PREVENTION ·+12
Upsher-Smith Laboratories
WARFARIN SODIUM
ORAL ANTICOAGULANTS · MYOCARDIAL REINFARCTION PREVENTION ·+12
EXELAN PHARMACE
AGGRASTAT (tirofiban HCl monohydrate)
GLYCOPROTEIN IIB/IIIA RECEPTOR INHIBITOR · NON Q-WAVE MYOCARDIAL INFARCTION ·+3
MEDICURE INTERN
ASPIRIN-DIPYRIDAMOLE ER (aspirin/dipyridamole)
ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW · PREVENTION OF CEREBRAL THROMBOSIS
Amneal Pharmaceuticals
AGGRASTAT (tirofiban HCl monohydrate in 0.9 % sodium chloride)
GLYCOPROTEIN IIB/IIIA RECEPTOR INHIBITOR · NON Q-WAVE MYOCARDIAL INFARCTION ·+3
MEDICURE INTERN
PRASUGREL HCL
ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW · MYOCARDIAL REINFARCTION PREVENTION ·+1
Mylan Pharmaceuticals
PRASUGREL HCL
ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW · MYOCARDIAL REINFARCTION PREVENTION ·+1
APOTEX CORP
PRASUGREL HCL
ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW · MYOCARDIAL REINFARCTION PREVENTION ·+1
AUROBINDO PHARM
PRASUGREL HCL
ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW · MYOCARDIAL REINFARCTION PREVENTION ·+1
ASCEND LABORATO
EPTIFIBATIDE
GLYCOPROTEIN IIB/IIIA RECEPTOR INHIBITOR · ACUTE CORONARY SYNDROME ·+1
ACCORD HEALTHCA
CILOSTAZOL
INTERMITTENT CLAUDICATION AGENTS · INTERMITTENT CLAUDICATION
SLATE RUN PHARM
KENGREAL (cangrelor tetrasodium)
ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW · PERCUTANEOUS CORONARY INTERVENTION ADJUNCT FOR THROMBOSIS PREVENTION
CHIESI USA, INC
WARFARIN SODIUM
ORAL ANTICOAGULANTS · MYOCARDIAL REINFARCTION PREVENTION ·+12
RISING PHARM
EPTIFIBATIDE
GLYCOPROTEIN IIB/IIIA RECEPTOR INHIBITOR · ACUTE CORONARY SYNDROME ·+1
SAGENT PHARMACE
EPTIFIBATIDE
GLYCOPROTEIN IIB/IIIA RECEPTOR INHIBITOR · ACUTE CORONARY SYNDROME ·+1
MYLAN INSTITUTI